Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-018317
Filing Date
2021-05-05
Accepted
2021-05-05 14:59:50
Documents
2
Period of Report
2021-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1612
2 EX-24 DOCUMENT attachment1.htm EX-24 4902
  Complete submission text file 0000899243-21-018317.txt   7961
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address COMPASS THERAPEUTICS, INC. 80 GUEST ST., SUITE 601 BOSTON MA 02135
Business Address
Kalled Susan (Reporting) CIK: 0001860504 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39696 | Film No.: 21892772